ObeEnd
展商：WAT Medical Enterprise Ltd.
原产国/地区：加拿大
超重和肥胖在世界范围内是快速增长的一个健康问题．超重和肥胖导致高血压、糖尿病、冠心病和脑卒中等相关疾病危机生命。所以，预防和治疗超重和肥胖是减少相关慢性病发病率的关键。 ObeEnd腕带是全球首款预防和治疗肥胖症的辅助设备，ObeEnd在加拿大康考迪亚大学完成三个医学研究，数据证明ObeEnd手环可减少卡路里摄入量，提高运动表现，从摄入和消耗两个角度帮助用户燃脂减重。智能引导用户以可持续有效的方式减肥，其设计理念被美联社、雅虎新闻、人民网、央视新闻等全球顶级媒体报道。 创新点： 1.ObeEnd为用户提供个性化的电刺激方案，增加基础代谢消耗，降低运动时的疲劳感知，提高运动表现，增加燃脂效率。 2.ObeEnd持续向手腕正中神经输出高精度的靶向电脉冲，电信号抵达大脑后形成饱腹感，大脑发出使胃部的蠕动降低的电信号，并有效减少胃酸的分泌。 3.ObeEnd创新研发具有导电功能的表带，使主机的设计变得灵活轻便，用户可用性更强。产品设计获得2021年IF与红点奖。通过美国联邦通讯委员会FCC和欧盟CE认证。 Overweight and obesity are a rapidly growing health problem worldwide. Obesity is a chronic, multifactorial metabolic disease that was listed by the World Health Organization in 1948 and is now recognized by the WHO as a global epidemic. Overweight and obesity are associated with high blood pressure, diabetes, coronary heart disease, and stroke. Therefore, preventing overweight and obesity is the key to controlling the burden of related chronic diseases. Traditional treatment of obesity is usually based on diet control, drug treatment, increase exercise. The main drawback is that it is hard to stick to. ObeEnd wristband, the world's first adjunct device to treat obesity, intelligently guide users to lose weight in a sustainable and effective way, whose design has been reported by the Associated Press, Yahoo News, and other top overseas media.
展品详情
超重和肥胖在世界范围内是快速增长的一个健康问题．超重和肥胖导致高血压、糖尿病、冠心病和脑卒中等相关疾病危机生命。所以，预防和治疗超重和肥胖是减少相关慢性病发病率的关键。
ObeEnd腕带是全球首款预防和治疗肥胖症的辅助设备，ObeEnd在加拿大康考迪亚大学完成三个医学研究，数据证明ObeEnd手环可减少卡路里摄入量，提高运动表现，从摄入和消耗两个角度帮助用户燃脂减重。智能引导用户以可持续有效的方式减肥，其设计理念被美联社、雅虎新闻、人民网、央视新闻等全球顶级媒体报道。
创新点：
1.ObeEnd为用户提供个性化的电刺激方案，增加基础代谢消耗，降低运动时的疲劳感知，提高运动表现，增加燃脂效率。
2.ObeEnd持续向手腕正中神经输出高精度的靶向电脉冲，电信号抵达大脑后形成饱腹感，大脑发出使胃部的蠕动降低的电信号，并有效减少胃酸的分泌。
3.ObeEnd创新研发具有导电功能的表带，使主机的设计变得灵活轻便，用户可用性更强。产品设计获得2021年IF与红点奖。通过美国联邦通讯委员会FCC和欧盟CE认证。
Overweight and obesity are a rapidly growing health problem worldwide. Obesity is a chronic, multifactorial metabolic disease that was listed by the World Health Organization in 1948 and is now recognized by the WHO as a global epidemic. Overweight and obesity are associated with high blood pressure, diabetes, coronary heart disease, and stroke. Therefore, preventing overweight and obesity is the key to controlling the burden of related chronic diseases.
Traditional treatment of obesity is usually based on diet control, drug treatment, increase exercise. The main drawback is that it is hard to stick to. ObeEnd wristband, the world's first adjunct device to treat obesity, intelligently guide users to lose weight in a sustainable and effective way, whose design has been reported by the Associated Press, Yahoo News, and other top overseas media.